![Amy Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 345 063 $ al 31/05/2026
Dr. Amy J.
Walker is a Chief Executive Officer & Director at 4basebio Plc.
She is on the Board of Directors at 4basebio Plc, Heqet Therapeutics Srl and Neomatrix SRL.
She received her doctorate degree from McGill University and a doctorate degree from the University of British Columbia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
4BASEBIO PLC 0,31 % | 21/05/2026 | 48.529 ( 0,31 % ) | 345 063 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 4BASEBIO PLC | Director Ejecutivo | 10/02/2026 |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in cardiac regenerative medicine | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4basebio Plc
 4basebio Plc BiotechnologyHealth Technology Develops gene therapy technologies and manufactures synthetic DNA | Health Technology |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in cardiac regenerative medicine | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
